GNPX

Genprex, Inc.

Healthcare · Biotechnology

$243.77 sample

-0.25 (-0.10%) 1D

Market cap

$184.1B

Price as of

2026-10-15

Latest filing

8-K · 2026-09-22

Alerts

8

Price$243.77 +14.14% 3M daily closessample

252.57213.58

2026-07-202026-08-112026-09-022026-09-232026-10-15

purchase / approvalsale / rejectionfiling / neutral

Latest events

Filings, trades, FDA; newest first

Oct 06INSInsider sell: Chief Financial Officer
Oct 01INSInsider sell: General Counsel
Sep 22SEC10-Q filed
Sep 16SEC8-K filed: material event
Sep 10INSInsider buy: EVP, Operations
Sep 04INSInsider sell: Director
Aug 31INSInsider sell: EVP, Operations
Aug 26SECForm 144 filed

Sign up to see the real GNPX record →

Company facts

SEC EDGAR registration

Name: Genprex, Inc.
Sector: Healthcare
Industry: Biotechnology
Smart-money score: +20sample, -100 to +100
Reporting currency: USD

Who is positioning in GNPX

sample

Insiders: 11 insider transactions over 90 days, net selling, $6.9M
Congress: No member trades over 90 days
Institutions · 13F: 40 funds hold $3.0B
Activists · 13D/G: No 13D/13G activist filings on record

How are the fundamentals trending?

sample, by period end

Revenue$11.5B +9.5% y/y

Q4 2024Q3 2026

Inventory$6.9B +5.1% y/y

Q4 2024Q3 2026

Accounts receivable$5.5B +11.9% y/y

Q4 2024Q3 2026

Total debt$14.3B +17.2% y/y

Q4 2024Q3 2026

Peers

sample

Sample peer A: $180.3B -3.0% 3M
Sample peer B: $91.2B -7.8% 3M
Sample peer C: $21.6B -9.6% 3M
Sample peer D: $44.7B +14.0% 3M
Sample peer E: $158.7B -11.7% 3M